Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06072547 · ClinicalTrials.gov registry record · NA

Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study

A NA study of Cigarette Smoking Behavior, sponsored by Altria Client Services.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT06072547: Recruiting NA study of Cigarette Smoking Behavior, sponsored by Altria Client Services.

NCT06072547 is a NA study of Cigarette Smoking Behavior that is actively recruiting participants, run by Altria Client Services. The registered enrollment target is 400 participants, below the 889-participant average among 4 other Cigarette Smoking Behavior trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06072547, a NA study of Cigarette Smoking Behavior, is actively recruiting participants, sponsored by Altria Client Services.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn about the role of flavored on!® nicotine pouch products (the research products), an oral tobacco-leaf-free product, in the replacement of cigarettes with the use of the research products among adults who smoke cigarettes. The main question it aims to answer is whether flavored (vs. non-flavored) research products generate greater reduction of cigarette smoking among adults who smoke cigarettes. Participants will be provided with research products to use for 6 weeks. Researchers will compare the reduction in cigarette smoking between participants with access to a complete flavor profile of research products and participants with access to only the Original (non-flavored) variety of research product to see if reduction in cigarette smoking is greater among those with access to flavored research products.

Conditions Studied

Interventions

  • OTHER Access to all varieties of on! 4mg nicotine pouches (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original)
  • OTHER Access to Original on! 4mg nicotine pouches
  • OTHER Non-Flavored then complete flavor on! nicotine pouches

Study Locations (1)

North Carolina

  • Rose Research Center - Raleigh

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-09-11
Est. Completion 2025-06
Phase NA
Altria Client Services

10 total trials

What NCT06072547 shows while recruiting

NCT06072547 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 889-participant average among 4 other Cigarette Smoking Behavior trials with a reported enrollment target (55% lower).

The record links to 1 condition, with Cigarette Smoking Behavior appearing as the primary indexed condition, and to 3 interventions - of which Access to all varieties of on! 4mg nicotine pouches (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original) is the first listed.

NCT06072547 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06072547 about?

NCT06072547 is a clinical study titled "Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study". The goal of this clinical trial is to learn about the role of flavored on!® nicotine pouch products (the research products), an oral tobacco-leaf-free product, in the replacement of cigarettes with the use of the research products among adults who smoke cigarettes. The main question it aims to answe...

What is the current status of trial NCT06072547?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-09-11. Estimated completion is 2025-06.

What conditions does trial NCT06072547 study?

This clinical trial studies the following conditions: Cigarette Smoking Behavior.

What interventions are being tested in trial NCT06072547?

The interventions under investigation include: Access to all varieties of on! 4mg nicotine pouches (Berry, Citrus, Cinnamon, Wintergreen, Mint, Coffee, and Original) (OTHER), Access to Original on! 4mg nicotine pouches (OTHER), Non-Flavored then complete flavor on! nicotine pouches (OTHER).

Who is sponsoring clinical trial NCT06072547?

This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06072547 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cigarette Smoking Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06072547, the US trial registry maintained by the National Library of Medicine. NCT06072547 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.